Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 21,981 shares at $37.11 ($822K) on 2026-03-16, disclosed to the SEC on 2026-03-18.
Scheduled sale ($822k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.11 | 13,196 | $490K | 59.6% |
| 2 | $37.77 | 8,785 | $332K | 40.4% |
| Total | $37.37 avg | 21,981 | $822K | 100% |
| Filing → |
| CRNX | SELL | 2024-12-04 | $576K | — | Filing → |
| CRNX | SELL | 2024-05-10 | $10.6M | — | Filing → |
| CRNX | SELL | 2024-04-08 | $4.0M | — | Filing → |